期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 410, 期 1-2, 页码 138-144出版社
ELSEVIER
DOI: 10.1016/j.ijpharm.2011.02.064
关键词
Puerarin; Solid lipid nanoparticles; Oral bioavailability; Pharmacokinetics; Rat; Liquid chromatography tandem mass spectrometry
资金
- National High Technology Research and Development Program of China (863 Program) [2007AA022002]
- Guangzhou Science and Technology Bureau [2007Z3-E5051]
- Program for Innovative Academic Team in Guangzhou Education System
Puerarin has various pharmacological effects; however, poor water-solubility and low oral bioavailability limit its clinical utility. A delivery system of solid lipid nanoparticles could enhance its oral absorption. The objective of this study was to investigate the pharmacokinetics, tissue distribution and relative bioavailability of puerarin in rats after a single dose intragastric administration of puerarin solid lipid nanoparticles (Pue-SLNs). The puerarin concentrations in plasma and tissues were determined by rapid resolution liquid chromatography electrospray ionization-tandem mass spectrometry. The C-max value of puerarin after the administration of Pue-SLNs was significantly higher than that obtained with puerarin suspension (0.33 +/- 0.05 mu g/mL vs. 0.16 +/- 0.06 mu g/mL, P < 0.01). The T-max value after the administration of the Pue-SLNs was significantly shorter than that after puerarin suspension administration (40 +/- 0 min vs. 110 +/- 15.49 min, P < 0.01). The AUC(0 -> t) values of puerarin were 0.80 +/- 0.23 mg h/L, and 2.48 +/- 0.30 mg h/L after administration of the puerarin suspension and Pue-SLNs, respectively. Following administration of the Pue-SLNs, tissue concentrations of puerarin also increased, especially in the target organs such as the heart and brain. These data suggest that SLNs are a promising delivery system to enhance the oral bioavailability of puerarin. (C) 2011 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据